000 01522 a2200397 4500
005 20250516092956.0
264 0 _c20130702
008 201307s 0 0 eng d
022 _a1873-7064
024 7 _a10.1016/j.neuropharm.2012.05.006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aO' Connor, Richard M
245 0 0 _aImpact of early-life stress, on group III mGlu receptor levels in the rat hippocampus: effects of ketamine, electroconvulsive shock therapy and fluoxetine treatment.
_h[electronic resource]
260 _bNeuropharmacology
_cMar 2013
300 _a236-41 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntidepressive Agents
_xpharmacology
650 0 4 _aElectroshock
_xmethods
650 0 4 _aExcitatory Amino Acid Antagonists
_xpharmacology
650 0 4 _aFluoxetine
_xpharmacology
650 0 4 _aHippocampus
_xdrug effects
650 0 4 _aKetamine
_xpharmacology
650 0 4 _aMale
650 0 4 _aMaternal Deprivation
650 0 4 _aN-Methylaspartate
_xantagonists & inhibitors
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aReceptors, Metabotropic Glutamate
_xagonists
650 0 4 _aStress, Psychological
_xmetabolism
700 1 _aPusceddu, Matteo M
700 1 _aDinan, Timothy G
700 1 _aCryan, John F
773 0 _tNeuropharmacology
_gvol. 66
_gp. 236-41
856 4 0 _uhttps://doi.org/10.1016/j.neuropharm.2012.05.006
_zAvailable from publisher's website
999 _c21794946
_d21794946